Anti-NMDA Receptor Encephalitis Clinical Pathway — Inpatient
Goals
- Standardize the assessment of children with anti-NMDARE by an experienced team
- Define treatment strategies for different facets of anti-NMDARE (psychiatric, autonomic, neurologic) and deploy these therapies consistently
- Establish an organized immunomodulatory treatment algorithm with escalation to higher potency therapies
Metrics
- Length of stay (hospital, ICU, rehabilitation)
- Cognitive testing
- % with testing at onset, discharge, 6 months, 12 months
- Cognitive testing scores
- Time to cognitive recovery
- Rate of intubation, tracheostomy, G-tube, polypharmacy